John Treace - Mar 8, 2022 Form 4 Insider Report for TREACE MEDICAL CONCEPTS, INC. (TMCI)

Role
Chief Executive Officer, Director, 10%+ Owner
Signature
/s/ Lisa Taylor as Attorney-in-fact for John T. Treace
Stock symbol
TMCI
Transactions as of
Mar 8, 2022
Transactions value $
$0
Form type
4
Date filed
3/10/2022, 07:24 PM
Previous filing
Dec 30, 2021
Next filing
Aug 24, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMCI Common Stock Award $0 +33.9K +0.62% $0.00 5.46M Mar 8, 2022 Direct F1, F2
holding TMCI Common Stock 1.61M Mar 8, 2022 By Wife F4
holding TMCI Common Stock 1.47M Mar 8, 2022 By Wife as cotrustee of the JTT Irrevocable Trust dated September 30, 2020 F4
holding TMCI Common Stock 1.84M Mar 8, 2022 As Trustee of the Tracy W. Treace Irrevocable Trust dated September 25, 2020 F5
holding TMCI Common Stock 409K Mar 8, 2022 As Co-Trustee of the John R. Treace Irrevocable Trust dated July 29, 2021 F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TMCI Stock Option (Right to Buy) Award $0 +241K $0.00 241K Mar 8, 2022 Common Stock 241K $19.15 Direct F3
transaction TMCI Stock Option (Right to Buy) Award $0 +20.9K $0.00 20.9K Mar 8, 2022 Common Stock 20.9K $21.07 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, commencing on March 8, 2023 with the last installment on March 8, 2026? subject to Reporting Person's providing continued service to Issuer through each vesting date.
F2 Includes 33,875 RSUs.
F3 The stock option will vest in equal annual installments over 4 years, commencing on March 8, 2023 with the last installment on March 8, 2026; subject to Reporting Person's providing continued service to Issuer through each vesting date.
F4 The Reporting Person disclaims beneficial ownership of shares held by his wife directly or in trusts for which his wife serves as trustee or co-trustee.
F5 The Reporting Person disclaims beneficial ownership of shares held in trust for which he serves as Trustee or Co-Trustee.